Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04676477 |
|---|---|
| Brief Title: | HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer |
| First Submitted : | December 15, 2020 |
| First Submitted that Met QC Criteria : | December 15, 2020 |
| First Posted : | December 21, 2020 |
| Last Update Submitted that Met QC Criteria : | April 26, 2024 |
| Last Update Posted : | April 30, 2024 |